-+ 0.00%
-+ 0.00%
-+ 0.00%

The innovative drug sector began to weaken, and the Kazakh Sanlian fell to a standstill, while Zhongguancun, Zhongsheng Pharmaceutical, Yibai Pharmaceutical, Shijiao Innovation, Sanyuan Gene, and Laimei Pharmaceutical followed suit.

智通財經·08/25/2026 01:41:21
語音播報
The innovative drug sector began to weaken, and the Kazakh Sanlian fell to a standstill, while Zhongguancun, Zhongsheng Pharmaceutical, Yibai Pharmaceutical, Shijiao Innovation, Sanyuan Gene, and Laimei Pharmaceutical followed suit.